2021
DOI: 10.1016/j.wneu.2021.01.089
|View full text |Cite
|
Sign up to set email alerts
|

Intraoperative Magnetic Resonance Imaging for Low-Grade and High-Grade Gliomas: What Is the Evidence? A Meta-Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 36 publications
1
13
0
Order By: Relevance
“…In contrast, Fountain et al 169 published a meta-analysis (including several RCTs, such as those reported by Senft et al 225 and Willems et al 4 ), which revealed that ioMR imaging might help to maximize the extent of resection in patients with high-grade glioma, although this conclusion was based on low-certainty evidence. This supported the findings of a previous review by Jenkinson et al 226 In a recent meta-analysis report by Lo et al, 227 the usage of ioMR imaging led to improved gross total resection of gliomas, but no benefits were seen for progression-free or overall survival.…”
Section: The Impact Of Intraoperative Imaging On Brain Tumor Surgerysupporting
confidence: 88%
“…In contrast, Fountain et al 169 published a meta-analysis (including several RCTs, such as those reported by Senft et al 225 and Willems et al 4 ), which revealed that ioMR imaging might help to maximize the extent of resection in patients with high-grade glioma, although this conclusion was based on low-certainty evidence. This supported the findings of a previous review by Jenkinson et al 226 In a recent meta-analysis report by Lo et al, 227 the usage of ioMR imaging led to improved gross total resection of gliomas, but no benefits were seen for progression-free or overall survival.…”
Section: The Impact Of Intraoperative Imaging On Brain Tumor Surgerysupporting
confidence: 88%
“…With the optimization and upgrade of medical imaging technology, image fusion technology has been applied in the assessment before and after brain gliomas surgery. This multimodal imaging modality uses computer technology to digitally and comprehensively process the image information acquired from various imaging examinations for multivariate data synergistic use and then generates a brand-new imaging after spatial registration [ 19 , 20 ]. It is beneficial for physicians to understand the comprehensive information of lesion tissues to develop more rational treatment regimens or evaluate the therapeutic effects.…”
Section: Discussionmentioning
confidence: 99%
“…Based on preoperative imaging, and overlap with FMRI-DTI, neuro-navigation allows preoperative identification of eloquent regions and guides the surgeon during intraoperative mapping and tumor resection [ 51 56 ] III C iCT: iCT helped to verify EOR and to identify and resect pathological tissue. iCT represents a feasible and effective alternative for intraoperative updates of the neuro-navigation system [ 11 , 57 ] III C iUS: iUS is a real-time, accurate and inexpensive imaging method for optimizing the EOR in neurosurgical interventions Despite being an operator-dependent method, iUS is associated with a greater EOR and improved PFS and OS in glioma patients [ 58 60 ] III C iMRI: iMRI was found to be associated with higher resection rates compared to the neuro-navigated procedures, Unfortunately, the high cost and the need for structural changes in the operating room have limited, to date, the spread of intraoperative MRI [ 59 64 ] III C 5-ALA: 5-ALA is a metabolic tracer that allows the intraoperative distinction of the boundaries between healthy tissue and tumor near the infiltration zones, thus guiding the glioma resection with an improved intraoperative enhancing vision [ 65 72 ] II B Fluorescence: sodium fluorescein (FLCN): The intraoperative guidance determined by FLCN allows to predict histopathological alterations both in areas with contrast enhancement and in the margins of infiltration of the cerebral parenchyma that do not present a neuroimaging contrast [ 60 , 70 , 73 76 ] III C Intraoperative treatment options In newly diagnosed HGGs, CWs implantations should not be considered as first-line therapeutic option [ 77 81 ] II B Estimation of extent of tumor resection ...…”
Section: Methodsmentioning
confidence: 99%